WO2023180964 - PYRAZINE AMIDE DERIVATIVES
National phase entry:
Publication Number
WO/2023/180964
Publication Date
28.09.2023
International Application No.
PCT/IB2023/052827
International Filing Date
22.03.2023
Title **
[English]
PYRAZINE AMIDE DERIVATIVES
[French]
DÉRIVÉS D'AMIDE DE PYRAZINE
Applicants **
NOVARTIS AG
Inventors
HUANG, Richard Yichong
KIRRANE JR., Thomas Martin
MARX, Vanessa
MATA, Anne-Catherine
SARKO, Christopher Ronald
TAFT, Benjamin Robert
YOKOKAWA, Fumiaki
Priority Data
63/269,879
24.03.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3358 | |
| EPO | Filing, Examination, Granting | 23542 | |
| Japan | Filing, Examination, Granting | 2955 | |
| South Korea | Filing, Examination, Granting | 3596 | |
| USA | Filing, Examination, Granting | 12190 |
Total:
45,641
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to pyrazine amide derivative compounds, such as those according to formula (I) and compositions including said compounds, The invention also provides such pyrazine amide derivative compounds for use in the treatment of plasmodium related diseases such as malaria.[French]
La présente invention concerne des composés dérivés d'amide de pyrazine, tels que ceux selon la formule (I) et des compositions comprenant lesdits composés, l'invention concerne également de tels composés dérivés d'amide de pyrazine à utiliser dans le traitement de maladies associées au plasmodium telles que le paludisme.